导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 26.89% | 2379/4484 |
| 近一周 | 0.06% | 2693/5079 |
| 近一月 | 0.03% | 1928/5013 |
| 近一季 | -10.94% | 4637/4886 |
| 近半年 | -5.08% | 4520/4661 |
| 近一年 | 17.87% | 2802/4456 |
| 近两年 | 7.87% | 3404/3963 |
| 近三年 | 5.12% | 2010/3306 |
| 成立以来 | 254.90% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
7.72% 1028/4617 |
13.44% 237/4794 |
12.93% 3744/4965 |
- - |
| 2024 | -12.97% 3765/4611 |
-8.77% 3358/4340 |
1.88% 868/4440 |
7.73% 3050/4543 |
-13.08% 4459/4611 |
| 2023 | -6.16% 640/4209 |
0.99% 2069/3759 |
-7.75% 2940/3909 |
-0.81% 347/4055 |
1.55% 295/4209 |
| 2022 | -26.17% 1955/3571 |
-14.40% 745/2804 |
3.83% 2245/3205 |
-18.77% 2941/3430 |
2.27% 1017/3570 |
| 2021 | -5.69% 1257/2712 |
-2.36% 672/1745 |
25.71% 163/2232 |
-9.26% 1656/2560 |
-15.33% 2383/2708 |
| 2020 | 81.98% 141/1591 |
18.72% 7/1036 |
38.08% 61/1256 |
-0.02% 1177/1472 |
11.04% 991/1690 |
| 2019 | 58.53% 141/922 |
24.69% 965/3054 |
1.60% 612/3201 |
19.58% 32/939 |
4.65% 827/1014 |
| 2018 | -3.94% 11/667 |
- - |
- - |
- - |
-12.88% 2492/2977 |
| 2017 | -0.89% 390/531 |
- - |
- - |
- - |
- - |
| 2016 | -24.91% 358/455 |
- - |
- - |
- - |
- - |
| 2015 | 72.20% 60/433 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8141 | 37.76% |
| 易方达标普生物科技人民币A | 1.7328 | 28.02% |
| 永赢先锋半导体智选混合发起C | 1.2684 | 26.99% |
| 银华集成电路混合A | 1.4951 | 23.93% |
| 华商致远回报混合A | 1.6291 | 23.20% |
| 华夏中证半导体材料设备主题ETF | 1.5851 | 22.62% |
| 天弘中证半导体材料设备主题指数发起C | 1.7561 | 21.34% |
| 诺安优化配置混合A | 2.5072 | 17.29% |
| 东方低碳经济混合C | 1.2657 | 17.06% |
| 广发生物科技指数美元(QDII)A | 0.2092 | 16.76% |
| 富国医疗保健行业混合A VS. () |